Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by SamV21on Nov 01, 2021 10:07am
46 Views
Post# 34072525

RE:RE:RE:RE:RE:ETF and Institutions

RE:RE:RE:RE:RE:ETF and Institutions Tetra Market Cap  is only 88.18 million now , shares diluted over and over and over again  and given away because they need money to keep the dreams going, dreams cost money sometimes too much money and I honestly don't think he has any idea how economically sound any of these dreams are, in the end will they be  profitable, I think it is anyones guess. I think the CFO did and said , I am out of here .We still don't know how much we are paying to Intelgenx to research and make Reduvo , they have given us gross income  guesses that is all , until we know what it costs we have no idea how much profit there is in Reduvo ,might be great science but maybe the big boys have done the math looked at the competion (nobilone made by Teva )and cost to market and concluded it just is not profitable enough  or is it the history of Guys start and stop and promises of other money makers that were all duds so far keeping them on the side lines .No one knows 100% when or if Health Canada will give approval on Reduvo.All we can do is wait . Guy needs results. Opinions ,good comment reports, working on this ,working on that , we are going to be doing this  and making  promises  don't  make shareholders any money.Reality is unless results happen, we will  still see lower prices than where we are at now.

<< Previous
Bullboard Posts
Next >>